Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities

Calcium Channel Blocker Verapamil Enhances Reticulum Stress and Death Induced by Proteasome Inhibition in Myeloma Cells

(2015) Silke Meister et al.   NEOPLASIA

Treatment-Induced Oxidative Stress and Cellular Antioxidant Capacity Determine Response to Bortezomib in Mantle Cell Lymphoma

(2011) M. A. Weniger et al.   CLINICAL CANCER RESEARCH

Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma

(2011) Hyun Joo Jung et al.   EXPERIMENTAL HEMATOLOGY

Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma

(2011) Hyun Joo Jung et al.   LEUKEMIA & LYMPHOMA

Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma

(2010) Jorge E. Romaguera et al.   BRITISH JOURNAL OF HAEMATOLOGY

A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer

(2010) S. P. Stratton et al.   Cancer Prevention Research

Mantle cell lymphoma: The promise of new treatment options

(2010) Andre Goy et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma

(2010) Clovis O. da Fonseca et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress

(2010) M Ri et al.   LEUKEMIA

Prospective isolation of clonogenic mantle cell lymphoma-initiating cells

(2010) Zheng Chen et al.   Stem Cell Research

Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin

(2009) Laxmi Yeruva et al.   ANTI-CANCER DRUGS

Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells

(2009) T. Hideshima et al.   BLOOD

Mantle cell lymphoma

(2009) S. A. Pileri et al.   HAEMATOLOGICA

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma

(2008) David T Yang et al.   Molecular Cancer